David Skurnik

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Nature communications

NPJ vaccines

Stem cell reviews and reports

PLoS pathogens

This page only lists publications with an associated author ORCID identifier.

Publications

Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Eliza Kramarska, Eya Toumi, Flavia Squeglia, Diana Laverde, Valeria Napolitano, Eric Frapy, Ida Autiero, Oceane Sadones, Johannes Huebner, David Skurnik, Felipe Romero-Saavedra, Rita Berisio
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens. NPJ vaccines 9 (1) (2024)
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Eliza Kramarska, Eya Toumi, Flavia Squeglia, Diana Laverde, Valeria Napolitano, Eric Frapy, Ida Autiero, Oceane Sadones, Johannes Huebner, David Skurnik, Felipe Romero-Saavedra, Rita Berisio
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens. NPJ vaccines 9 (1) (2024)
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Eliza Kramarska, Eya Toumi, Flavia Squeglia, Diana Laverde, Valeria Napolitano, Eric Frapy, Ida Autiero, Oceane Sadones, Johannes Huebner, David Skurnik, Felipe Romero-Saavedra, Rita Berisio
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens. NPJ vaccines 9 (1) (2024)
Kenneth Johnson, James C Delaney, Thomas Guillard, Fany Reffuveille, Jennifer Varin-Simon, Kai Li, Andrew Wollacott, Eric Frapy, Surin Mong, Hamid Tissire, Karthik Viswanathan, Faycal Touti, Gregory J Babcock, Zachary Shriver, Bradley L Pentelute, Obadiah Plante, David Skurnik
Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections. PLoS pathogens 19 (9) (2023)
Stéphanie Pons, Fabrice Uhel, Eric Frapy, Youssouf Sérémé, Lara Zafrani, Hugues Aschard, David Skurnik
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? Stem cell reviews and reports (2022)
Alexis Rybak, David Dawei Yang, Cécile Schrimpf, Romain Guedj, Corinne Levy, Robert Cohen, Vincent Gajdos, Julie Tort, David Skurnik, Naïm Ouldali, François Angoulvant
Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis. Pathogens (Basel, Switzerland) 10 (11) (2021)
Hugues Aschard, Vincent Laville, Eric Tchetgen Tchetgen, Dan Knights, Floris Imhann, Philippe Seksik, Noah Zaitlen, Mark S Silverberg, Jacques Cosnes, Rinse K Weersma, Ramnik Xavier, Laurent Beaugerie, David Skurnik, Harry Sokol
Genetic effects on the commensal microbiota in inflammatory bowel disease patients. PLoS genetics 15 (3) (2019)

David Skurnik.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Skurnik